New drug tested for people whose epilepsy Won't respond to standard treatments
Disease control
Completed
This study tested an investigational drug called RAP-219 in 30 adults with focal epilepsy that does not respond well to current medications. The main goal was to see if RAP-219 safely reduces the frequency of seizures. Participants had a special implanted brain device that helped…
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC